表紙
年間契約型資訊服務

新藥研發產品線資料庫:年度訂閱

R&D Drug Pipeline Database: 1-Year Subscription

出版商 La Merie Publishing 商品編碼 302689
出版日期 年間契約型資訊服務 內容資訊 英文
價格
Back to Top
新藥研發產品線資料庫:年度訂閱 R&D Drug Pipeline Database: 1-Year Subscription
出版日期: 年間契約型資訊服務內容資訊: 英文
簡介

本年度資訊服務可全天候在線點閱關於市場上新藥研發的23,400多個項目計劃和研發中的候選研究藥物信息。刊載各計劃標的·化合物類別·產品類型·開發企業·地區·治療領域·適應症·開發階段等的詳細資料。

本資料庫的優點

  • 可直觀利用
  • 可24小時線上查詢
  • 支援結構搜尋
  • 專注於目標,產品類別和研發階段
  • 競爭對手分析的理想選擇(公司,目標,產品類別)
  • 經濟高效且快速的基準測試解決方案
  • 確定候選許可證

刊載項目

  • 藥品編碼
  • 標的/ 作用機制
  • 化合物類別
  • 產品類型
  • 企業
  • 領域
  • 治療領域
  • 適應症
  • R&D階段

產品類型

  • 抗體
  • 細胞
  • DNA
  • 胜肽
  • 蛋白質
  • RNA
  • 小分子
  • 疫苗

治療領域

  • 心臟血管·血液·急性期治療
  • 皮膚科
  • 消化器官科
  • 尿生殖器·婦產科·腎臟
  • 感染疾病·毒素
  • 代謝·內分泌系
  • 神經·神經科
  • 癌症
  • 眼科·耳鼻喉科
  • 整形外科·牙科·麻醉·外科
  • 肺·呼吸系統
  • 類風濕和自身免疫

標的:事前設定下拉滾動選單範例

  • 抗體藥物複合體 (ADC)
  • 抗體·蛋白質的銷售額
  • 細胞內標的 (MAGE-A·NY-ESO-1·PRAME等)
  • 免疫腫瘤標的 (PD-1·PD-L1·CTLA-4·LAG-3,TIM-3·4-1BB·CD73等)
  • CAR&TCR改變T細胞·NK細胞
  • Adalimumab (Humira) 生物相似藥
  • Her2抗體
  • 雙特異性抗體
  • 腫瘤溶解性病毒 (腺病毒·牛痘·HSV等)
  • 伊波拉病毒疫苗·治療藥
  • 凝血因子
  • 肉毒桿菌神經毒素
  • PTH-R受體激動劑
  • 心臟代謝胜肽

技術:事前設定下拉滾動選單範例

  • 轉基因XenoMouse抗體
  • T細胞重定向雙特異性抗體
  • 受體激動劑抗體
  • TCR樣抗體·融合蛋白質
  • ADC (抗體藥物複合體):吡咯並苯並二氮雜卓(PBD)
  • FC融合蛋白質
  • oligo·多株抗體
目錄
Product Code: LMDB0004

Subscription to La Merie Publishing's proprietary ‘R&D Drug Pieline Database’ provides 24/7 online access to information about more than 23,400 project entries (files) for therapeutic drugs on the market and on investigational drug candidates in research & development. Pre-established and free search functions allow to identify molecules according to their

  • Product category (NCE, antibodies, proteins, DNA, RNA, cells, vaccines, peptides)
  • Technology (e.g.engineered T-cells, antibody-drug conjugate, bispecific antibody)
  • Target (e.g. Her2, BCMA, PD-1, RORgamma)
  • Pipelines (selected by target, therapeutic area, company, technology)
  • Sales (for marketed antibodies, peptides and proteins)
  • R&D Phase (clinical phases, market, preclinical)
  • Territory (countrywise)
  • Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
  • Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D Drug Pipeline Database is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antibodies, proteins and peptides on the market are provided.

An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.

Special Focus of the Database:

  • Immuno-Oncology
  • Biosimilars
  • Antibodies
  • mRNA
  • Engineered Cells
  • Oncolytic viruses
  • Therapeutic Proteins
  • Peptides
  • Vaccines

Prerequisite: Internet access.

Purchase of the subscription provides a 1-year online access to the data of the R&D Drug Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the R&D Drug Pipeline Database:

  • Intuitive use
  • 24/7 online access
  • Designed for structured searches
  • Focused on targets, product categories and R&D phases
  • Ideal for competitor analysis (companies, targets, product categories)
  • Cost-effective and rapid solution for benchmarking
  • Identification of licensing candidates

Project listing in a tabular format:

  • Drug Codes
  • Target / Mechanism of Action
  • Class of Compound
  • Product Category
  • Company
  • Territory
  • Therapeutic Area
  • Indication
  • R&D Phase

Product Categories:

  • Antibody
  • Cell
  • DNA
  • Peptide
  • Protein
  • RNA
  • Small Molecule
  • Vaccine

Therapeutic Areas:

  • Cardiovascular, blood & acute care
  • Dermatology
  • Gastrointestinal
  • Genitourinary, gynecology & renal
  • Infectious & toxicology
  • Metabolism & endocrine
  • Neurology & psychiatry
  • Oncology
  • Ophthalmolgoy & otorhinolaryngology
  • Orthopedics, dental, anesthesia & surgery
  • Pulmonary & respiratory
  • Rheumatoid & autoimmune

Examples of Predefined Targets of the Scroll Down Menu:

  • Antibody-Drug Conjugates (ADC)
  • Sales of Antibodies & Proteins 2017
  • Intracellular targets (MAGE-A, NY-ESO-1, PRAME etc)
  • Immuno-oncology targets (PD-1, PD-L1, CTLA-4, LAG-3,TIM-3, 4-1BB, CD73 etc)
  • CAR & TCR Engineered T-Cells and NK Cells
  • Adalimumab (Humira) Biosimilars
  • Her2 Antibodies
  • Bispecific Antibodies
  • Oncolytic Viruses (adenovirus, vaccinia, HSV etc)
  • Ebola Virus Vaccines & Therapeutics
  • Coagulation Factors
  • Botulinum Neurotoxins
  • PTH-R Agonists
  • Cardiometabolic Peptides

Examples of Predefined Technologies of the Scroll Down Menu:

  • Transgenic XenoMouse Antibodies
  • T-Cell Redirecting Bispecific Antibodies
  • Agonistic Antibodies
  • TCR-like Antibodies & Fusion Proteins
  • ADC - Pyrrolobenzodiazepine (PBD)
  • Fc-Fusion Proteins
  • Oligo- and Polyclonal Antibodies

Sample Screenshots of R&D Drug Pipeline Database
as of November 12, 2014.

Back to Top